IO Biotech, Inc. (IOBT) Financials
IOBT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 150.7 million | 17.6 million |
2023-09-30 | 172.6 million | 15.0 million |
2023-06-30 | 117.6 million | 13.0 million |
2023-03-31 | 136.8 million | 12.6 million |
IOBT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -22.9 million | 1.6 million |
2023-09-30 | -16.0 million | 3.0 million |
2023-06-30 | -18.3 million | 1.6 million |
2023-03-31 | -14.8 million | 1.9 million |
IOBT Net Income
No data available :(
IOBT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 143.2 million | - | 2.5 million |
2023-09-30 | 165.5 million | - | 2.6 million |
2023-06-30 | 110.1 million | - | 2.8 million |
2023-03-31 | 128.5 million | - | 2.8 million |
IOBT Shares Outstanding
IOBT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 112000 | 21.8 million | 6.4 million | -201000 |
2023-09-30 | 24000 | 17.7 million | 5.8 million | - |
2023-06-30 | 39000 | 16.5 million | 5.3 million | - |
2023-03-31 | 148000 | 11.9 million | 6.0 million | - |
IOBT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 201000 |
2023-09-30 | - | 194000 |
2023-06-30 | - | 187000 |
2023-03-31 | - | 174000 |
IOBT
Price: $1.57
52 week price:
Earnings Per Share: -1.98 USD
P/E Ratio: -0.70
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 106527
Market Capitalization: 102.1 million